# Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Study · id `cardio:ct-nct03021928` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03021928](<https://clinicaltrials.gov/study/NCT03021928>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03021928

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.

## Technical summary

Registry record NCT03021928. Randomized; single masking; primary purpose prevention. Start 2017-06-14 (actual); primary completion 2023-08-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT03021928, source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)
- Started: 2017-06-14 (actual) (ClinicalTrials.gov record NCT03021928, source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)
- Primary completion: 2023-08-03 (actual) (ClinicalTrials.gov record NCT03021928, source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)
- Completion: 2023-12 (anticipated) (ClinicalTrials.gov record NCT03021928, source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03021928, source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03021928-2023-08-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
- Acronym: START
- Condition: Stroke
- Intervention (Other): Time-To-Treatment Randomization
- Lead sponsor: University of Texas at Austin
- Lead sponsor class: OTHER
- Collaborator: Lone Star Stroke Research Consortium
- Collaborator class: UNKNOWN
- Collaborator: Texas Department of State Health Services
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Texas at Austin (`cardio:org-university-of-texas-at-austin`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial (`cardio:pubmed-40163159`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5f2eeb499509346830f4143f52306d41d4c1182efce746f341ab39115998c52a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
